drugset / Trial / NCT00138528

Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

NCT00138528

Phase 4 Completed 55 enrolled Novartis
RandomizedCrossoverDouble-blindTreatment

Summary

Other effects of fluvastatin are investigated in German patients with metabolic syndrome.

Timeline

Start
2004-10
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvastatin Other / unclassified 40 mg
Subject Fluvastatin Other / unclassified 80 mg

Indications